NOT KNOWN DETAILS ABOUT LEUKOTRIENE D4

), allows to explain why KIF15 will be able to facilitate resistance to Eg5 inhibitors in vivo. MT gliding driven by both of these mitotic motors was arrested only every time they have been independently inhibited, lending assist to the proposal that a mixture drug therapy focusing on these motors could be a workable strategy for overcoming chemoth